AAD-NPF 银屑病外用治疗与替代医学及严重程度评估联合指南
该指南由美国皮肤病学会(AAD)与国家银屑病基金会(NPF)联合制定,针对银屑病外用药物、替代医学治疗及成人严重程度评估的临床问题给出循证推荐。指南强调皮肤科医生在监测与教育患者获益和风险中的作用。
要点
- 指南覆盖银屑病外用治疗、替代医学及成人严重程度评估方法
- 推荐基于现有证据,强调皮肤科医生对患者的监测与教育
- 银屑病为慢性炎症性多系统疾病,美国患病率最高达3.2%
核心结论
- 指南针对银屑病外用药物、替代医学治疗及成人严重程度评估提供基于现有证据的推荐。
研究设计与样本
- 由美国皮肤病学会(AAD)与国家银屑病基金会(NPF)联合制定指南,基于现有证据回答银屑病管理中的临床问题。
主要发现
- 银屑病为慢性炎症性多系统疾病,影响美国人口比例最高达3.2%。
临床怎么用
- 皮肤科医生应依据指南选择外用药物与替代医学方案,并监测和教育患者相关获益与风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the United States population. This guideline addresses important clinical questions that arise in psoriasis management and care and provides recommendations based on the available evidence. The treatment of psoriasis with topical agents and with alternative medicine will be reviewed, emphasizing treatment recommendations and the role of dermatologists in monitoring and educating patients regarding benefits as well as risks that may be associated. This guideline will also address the severity assessment methods of psoriasis in adults.
引用
- Elmets CA, Korman NJ, Prater EF, et al. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2020. PMID: 32738429. doi:10.1016/j.jaad.2020.07.087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。